Literature DB >> 16490428

Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome.

Mehmet Birhan Yilmaz1, Vedat Caldir, Yesim Guray, Umit Guray, Hakan Altay, Burcu Demirkan, Serkan Cay, Halil L Kisacik, Sule Korkmaz.   

Abstract

Development of coronary collaterals (CCs) is triggered by the gradient between arteries due to obstruction and myocardial ischemia. Presence of CCs that feed the jeopardized myocardial area may limit the infarct size after coronary occlusion and may even provide a survival benefit. However, some patients develop good CCs, whereas others do not. The metabolic syndrome (MS) has been identified as a secondary target to decrease cardiovascular risk, although the effect of MS on development of CCs has not been investigated. We prospectively enrolled 596 consecutive patients (337 men and 259 women; mean age 56 +/- 8 years) who underwent coronary angiography at our center and were found to have total occlusion of the right coronary artery. Patients were then classified as having good CCs (Rentrop's grades 2 to 3) or poor CCs (Rentrop's grades 0 to 1). There were significant differences in terms of body mass index (kilograms of body weight divided by square meters of height), glucose levels, triglyceride levels, and years with angina pectoris between those with good and poor CCs. Prevalences of diabetes mellitus were 27.1% among patients with good CCs and 44% among those with poor CCs (p <0.001). Presence of MS was significantly higher in patients with poor CCs than in those with good CCs (78.4% vs 49.2%, p <0.001). In regression analysis, duration of angina pectoris (beta = 0.347, 95% confidence interval [CI] 0.266 to 0.453, p <0.001), presence of diabetes mellitus (beta = 1.829, 95% CI 1.021 to 3.279, p = 0.042), wall score (beta = 2.379, 95% CI 1.356 to 4.173, p = 0.003), and presence of MS (beta = 2.993, 95% CI 1.541 to 5.813, p = 0.001) were independent predictors of angiographically determined poor CCs. In conclusion, MS seems to be independently associated with poor CCs in patients with an occluded right coronary artery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490428     DOI: 10.1016/j.amjcard.2005.09.103

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Impaired compensation to femoral artery ligation in diet-induced obese mice is primarily mediated via suppression of collateral growth by Nox2 and p47phox.

Authors:  Matthew R DiStasi; Julie A Mund; H Glenn Bohlen; Steven J Miller; David A Ingram; Michael C Dalsing; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-21       Impact factor: 4.733

Review 2.  Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?

Authors:  Petra Rocic
Journal:  Vascul Pharmacol       Date:  2012-02-09       Impact factor: 5.773

3.  Association of arterial calcification with chronic limb ischemia in patients with peripheral artery disease.

Authors:  Sara L Zettervall; Andre P Marshall; Paul Fleser; Raul J Guzman
Journal:  J Vasc Surg       Date:  2017-09-01       Impact factor: 4.268

4.  MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome.

Authors:  Rebecca Hutcheson; Russell Terry; Jennifer Chaplin; Erika Smith; Alla Musiyenko; James C Russell; Thomas Lincoln; Petra Rocic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-07       Impact factor: 8.311

Review 5.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

6.  Assessment of the presence and extent of coronary collateralization by coronary computed tomographic angiography in patients with total occlusions.

Authors:  Johannes Rieber; Tej N Sheth; Eline A Q Mooyaart; Michael D Shapiro; Javed Butler; Maros Ferencik; Thomas J Brady; Volker Klauss; Udo Hoffmann
Journal:  Int J Cardiovasc Imaging       Date:  2008-11-20       Impact factor: 2.357

7.  Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study.

Authors:  Tong Liu; Zheng Wu; Jinghua Liu; Yun Lv; Wenzheng Li
Journal:  Cardiovasc Diabetol       Date:  2021-05-10       Impact factor: 9.951

Review 8.  The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration.

Authors:  Rebecca Hutcheson; Petra Rocic
Journal:  Exp Diabetes Res       Date:  2012-07-09

9.  A device for performing automated balloon catheter inflation ischemia studies.

Authors:  Silas J Leavesley; Whitley Ledkins; Petra Rocic
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

Review 10.  Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain.

Authors:  Abdoulaye Diane; W David Pierce; Sandra E Kelly; Sharon Sokolik; Faye Borthwick; Miriam Jacome-Sosa; Rabban Mangat; Jesus Miguel Pradillo; Stuart McRae Allan; Megan R Ruth; Catherine J Field; Rebecca Hutcheson; Petra Rocic; James C Russell; Donna F Vine; Spencer D Proctor
Journal:  Front Nutr       Date:  2016-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.